UB
HZNP

UMB Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

UMB Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-329
Closed -$38.1K – 1780
2023
Q3 		$38.1K Hold
329
– – ﹤0.01% 895
2023
Q2 		$33.8K Hold
329
– – ﹤0.01% 945
2023
Q1 		$35.9K Hold
329
– – ﹤0.01% 922
2022
Q4 		$38K Hold
329
– – ﹤0.01% 927
2022
Q3 		$20K Buy
329
+16
+5% +$1.12K ﹤0.01% 1117
2022
Q2 		$25K Hold
313
– – ﹤0.01% 1099
2022
Q1 		$33K Hold
313
– – ﹤0.01% 1082
2021
Q4 		$34K Buy
+313
New +$34.1K ﹤0.01% 1114

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UMB Bank's HZNP Position: Q4 2023 in Review

UMB Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 329 shares — an estimated $38.1K sold.

UMB Bank first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $38.1K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • UMB Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • UMB Bank sold 329 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $38.1K.
  • UMB Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • UMB Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $38.1K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on UMB Bank's 13F filing for Q4 2023, filed 23 Jan 2024.